Bleeding events in patients with acute coronary syndrome (ACS) are associated with poor outcomes. Risk factors and their associations with in-hospital events in older patients with ACS are not fully understood because older ...
May 25, 2023
0
12
Americans with COVID-19 have been taking Paxlovid since it was approved under emergency use in late 2021. Today, the U.S. Food and Drug Administration granted full approval to the drug.
May 25, 2023
0
15
Impaired function of lung fibroblast is considered causative for symptoms of the incurable lung disease COPD (Chronic Obstructive Pulmonary Disease). Using high-resolution epigenetic profiling, German and British scientists ...
May 24, 2023
0
3
Previous studies have shown that the mortality rate of COVID-19 patients hospitalized and requiring oxygen therapy is similar no matter if they are vaccinated or unvaccinated.
May 23, 2023
0
12
New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar rates of recurrent coronary revascularization, major adverse cardiac and cerebrovascular ...
May 20, 2023
0
2
A new study examining the criteria proposed by the European Society of Cardiology (ESC) to prescribe long-term treatment with more than one blood thinner after percutaneous coronary intervention was presented today as late-breaking ...
May 19, 2023
0
5
Findings from the first-in-human trial of a novel percutaneous ventricular assist device (pVAD) were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) ...
May 18, 2023
0
23
Anna Falk at the research group Thoracic Surgery, Department of Molecular Medicine and Surgery, will defend her thesis "Depression and delirium in cardiac surgery patients" on May 26, 2023. Here main Supervisor is Malin Stenman.
May 17, 2023
0
2
Long COVID risk has been found to increase with low levels of vitamin D, according to research presented at the 25th European Congress of Endocrinology in Istanbul. The findings suggest that individuals should have their ...
May 13, 2023
0
114
GLP1 receptor agonists—a class of diabetes medications—are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease. ...
May 8, 2023
0
43
